CHRONIC MYELOID LEUKEMIA (CML)
Clinical trials for CHRONIC MYELOID LEUKEMIA (CML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA (CML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA (CML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can patients stop Anti-Rejection drugs sooner after transplant?
Disease control Not yet recruitingThis study tests whether patients can safely stop the drug tacrolimus earlier than usual after a stem cell transplant. Tacrolimus is given to prevent graft-versus-host disease (GVHD), but newer methods have lowered GVHD risk. The trial will enroll 50 people with blood cancers and…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New DNA test could spot leukemia resistance earlier
Diagnosis Not yet recruitingThis study will test whether a highly sensitive genetic test called digital PCR can detect drug-resistant mutations in people with chronic myeloid leukemia (CML) as well as the current standard method. Researchers will analyze blood samples from 150 adults with CML whose current …
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: NA • Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Diagnosis
Last updated Jun 26, 2026 14:03 UTC
-
Personalized exercise shows promise for fatigue in rare blood cancers
Symptom relief Not yet recruitingThis study tests whether a 12-week personalized exercise program can reduce fatigue and improve physical function in people with myeloproliferative neoplasms (MPN) and chronic myeloid leukemia (CML). Participants will do supervised aerobic and resistance training twice a week plu…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: NA • Sponsor: Carmen Fava • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC